Platelet-derived growth factor-BB transactivates the fibroblast growth factor receptor to induce proliferation in human smooth muscle cells

Trends in Cardiovascular Medicine

Volumn 16, Issue 1, 2006, Pages 25-28

  Millette, Esther ^a,b   Rauch, Bernhard H ^a,c   Kenagy, Richard D ^a   Daum, Guenter ^a   Clowes, Alexander W ^a  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b Trans BIO Tech   (Canada)

^c UNIVERSITY HOSPITAL DÜSSELDORF   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

FIBROBLAST GROWTH FACTOR 2; FIBROBLAST GROWTH FACTOR RECEPTOR; HEPARAN SULFATE; HEPARIN; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PHOSPHATIDYLINOSITOL 3 KINASE; PLATELET DERIVED GROWTH FACTOR BB; PLATELET DERIVED GROWTH FACTOR RECEPTOR; PROTEIN KINASE C; PROTEOGLYCAN;

CELL MIGRATION; CELL PROLIFERATION; ENZYME ACTIVATION; HUMAN; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; REVIEW; SMOOTH MUSCLE FIBER;

ENZYME ACTIVATION; FIBROBLAST GROWTH FACTOR 2; HEPARAN SULFATE PROTEOGLYCANS; HUMANS; MUSCLE, SMOOTH, VASCULAR; PLATELET-DERIVED GROWTH FACTOR; RECEPTORS, FIBROBLAST GROWTH FACTOR; SIGNAL TRANSDUCTION; TRANS-ACTIVATION (GENETICS);

EID: 29444452877     PISSN: 10501738     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tcm.2005.11.003     Document Type: Review

References (52)

1. P Chan, M Patel, and L Betteridge Abnormal growth regulation of vascular smooth muscle cells by heparin in patients with restenosis Lancet 341 1993 341 342
2. AK Chan, A Kalmes, and S Hawkins Blockade of the epidermal growth factor receptor decreases intimal hyperplasia in balloon-injured rat carotid artery J. Vasc. Surg. 37 2003 644 649
3. GC Cheng, WH Briggs, and DS Gerson Mechanical strain tightly controls fibroblast growth factor-2 release from cultured human vascular smooth muscle cells Circ. Res. 80 1997 28 36
4. S Clasper, S Vekemans, and M Fiore Inducible expression of the cell surface heparan sulfate proteoglycan syndecan-2 (fibroglycan) on human activated macrophages can regulate fibroblast growth factor action J. Biol. Chem. 274 1999 24113 24123
5. DD Cornelison, SA Wilcox-Adelman, and PF Goetinck Essential and separable roles for syndecan-3 and syndecan-4 in skeletal muscle development and regeneration Genes Dev. 18 2004 2231 2236
6. JR Couchman, L Chen, and A Woods Syndecans and cell adhesion Int. Rev. Cytol. 207 2001 113 150
7. H Daub, FU Weiss, and C Wallasch Role of transactivation of the EGF receptor in signalling by G-protein-coupled receptors Nature 379 1996 557 560
8. G Daum, U Hedin, and Y Wang Diverse effects of heparin on mitogen-activated protein kinase-dependent signal transduction in vascular smooth muscle cells Circ. Res. 81 1997 17 23
9. SP Evanko, EW Raines, and R Ross Proteoglycan distribution in lesions of atherosclerosis depends on lesion severity, structural characteristics, and the proximity of platelet-derived growth factor and transforming growth factor-beta Am. J. Pathol. 152 1998 533 546
10. KE Forsten, NA Courant, and MA Nugent Endothelial proteoglycans inhibit bFGF binding and mitogenesis J. Cell. Physiol. 172 1997 209 220
11. JM Herbert, M Clowes, and HJ Lea Protein kinase C α expression is required for heparin inhibition of rat smooth muscle cell proliferation in vitro and in vivo J. Biol. Chem. 271 1996 25928 25935
12. A Horowitz, and M Simons Phosphorylation of the cytoplasmic tail of syndecan-4 regulates activation of protein kinase C alpha J. Biol. Chem. 273 1998 25548 25551
13. CL Jackson, and MA Reidy Basic fibroblast growth factor: Its role in the control of smooth muscle cell migration Am. J. Pathol. 143 1993 1024 1031
14. SM Jones, and A Kazlauskas Growth factor-dependent signaling and cell cycle progression FEBS Lett. 490 2001 110 116
15. SM Jones, R Klinghoffer, and GD Prestwich PDGF induces an early and a late wave of PI 3-kinase activity, and only the late wave is required for progression through G1 Curr. Biol. 9 1999 512 521
16. M Jones, L Tussey, and N Athanasou Heparan sulfate proteoglycan isoforms of the CD44 hyaluronan receptor induced in human inflammatory macrophages can function as paracrine regulators of fibroblast growth factor action J. Biol. Chem. 275 2000 7964 7974
17. A Kalmes, BR Vesti, and G Daum Heparin blockade of thrombin-induced smooth muscle cell migration involves inhibition of epidermal growth factor (EGF) receptor transactivation by heparin-binding EGF-like growth factor Circ. Res. 87 2000 92 98
18. M Kato, HM Wang, and V Kainulainen Physiological degradation converts the soluble syndecan-1 ectodomain from an inhibitor to a potent activator of FGF-2 Nat. Med. 4 1998 691 697
19. MG Kinsella, PK Tran, and MCM Weiser-Evans Changes in perlecan expression during vascular injury-role in the inhibition of smooth muscle cell proliferation in the late lesion Arterioscler. Thromb. Vasc. Biol. 23 2003 608 614
20. MG Kinsella, C Irvin, and MA Reidy Removal of heparan sulfate by heparinase treatment inhibits FGF-2-dependent smooth muscle cell proliferation in injured rat carotid arteries Atherosclerosis 175 2004 51 57
21. M Kohno, K Yokokawa, and K Yasunari Induction by lysophosphatidylcholine, a major phospholipid component of atherogenic lipoproteins, of human coronary artery smooth muscle cell migration Circulation 98 1998 353 359
22. E Landgren, A Eriksson, and S Wennström Induction of fibroblast growth factor receptor-1 mRNA and protein by platelet-derived growth factor BB Exp. Cell. Res. 223 1996 405 411
23. V Lindner, DA Lappi, and A Baird Role of basic fibroblast growth factor in vascular lesion formation Circ. Res. 68 1991 106 113
24. V Lindner, NE Olson, and AW Clowes Inhibition of smooth muscle cell proliferation in injured rat arteries. Interaction of heparin with basic fibroblast growth factor J. Clin. Invest. 90 1992 2044 2049
25. C Maasch, S Wagner, and C Lindschau Protein kinase c alpha targeting is regulated by temporal and spatial changes in intracellular free calcium concentration [Ca(2+)](i) FASEB J. 14 2000 1653 1663
26. M Mali, K Elenius, and HM Miettinen Inhibition of basic fibroblast growth factor-induced growth promotion by overexpression of syndecan-1 J. Biol. Chem. 268 1993 24215 24222
27. S Meloche Cell cycle reentry of mammalian fibroblasts is accompanied by the sustained activation of p44mapk and p42mapk isoforms in the G1 phase and their inactivation at the G1/S transition J. Cell. Physiol. 163 1995 577 588
28. S Meloche, K Seuwen, and G Pages Biphasic and synergistic activation of p44mapk (ERK1) by growth factors: Correlation between late phase activation and mitogenicity Mol. Endocrinol. 6 1992 845 854
29. P Mignatti, T Morimoto, and DB Rifkin Basic fibroblast growth factor, a protein devoid of secretory signal sequence, is released by cells via a pathway independent of the endoplasmic reticulum-Golgi complex J. Cell. Physiol. 151 1992 81 93
30. E Millette, BH Rauch, and O Defawe Platelet-derived growth factor-BB-induced human smooth muscle cell proliferation depends on basic FGF release and FGFR-1 activation Circ. Res. 96 2005 172 179
31. L Muthukrishnan, E Warder, and PL McNeil Basic fibroblast growth factor is efficiently released from a cytolsolic storage site through plasma membrane disruptions of endothelial cells J. Cell. Physiol. 148 1991 1 16
32. MA Nugent, MJ Karnovsky, and ER Edelman Vascular cell-derived heparan sulfate shows coupled inhibition of basic fibroblast growth factor binding and mitogenesis in vascular smooth muscle cells Circ. Res. 73 1993 1051 1060
33. ES Oh, A Woods, and JR Couchman Multimerization of the cytoplasmic domain of syndecan-4 is required for its ability to activate protein kinase C J. Biol. Chem. 272 1997 11805 11811
34. 1 integrin and disassembly of actin filaments Circ. Res. 80 1997 627 637
35. N Prenzel, E Zwick, and H Daub EGF receptor transactivation by G-protein-coupled receptors requires metalloproteinase cleavage of proHB-EGF Nature 402 1999 884 888
36. M Presta, P Dell'Era, and S Mitola Fibroblast growth factor/fibroblast growth factor receptor system in angiogenesis Cytokine Growth Factor Rev. 16 2005 159 178
37. LA Pukac, JJ Castellot, and TC Wright Heparin inhibits c-fos and c-myc mRNA expression in vascular smooth muscle cells Cell Regul. 1 1990 435 443
38. EW Raines PDGF and cardiovascular disease Cytokine Growth Factor Rev. 15 2004 237 254
39. BH Rauch, E Millette, and RD Kenagy Thrombin- and factor Xa-induced DNA synthesis is mediated by transactivation of fibroblast growth factor receptor-1 in human vascular smooth muscle cells Circ. Res. 94 2004 340 345
40. BH Rauch, E Millette, and RD Kenagy Syndecan-4 is required for thrombin-induced migration and proliferation in human vascular smooth muscle cells J. Biol. Chem. 2005
41. JS Refson, M Schachter, and MK Patel Vein graft stenosis and the heparin responsiveness of human vascular smooth muscle cells Circulation 97 1998 2506 2510
42. C Rutherford, W Martin, and M Salame Substantial inhibition of neo-intimal response to balloon injury in the rat carotid artery using a combination of antibodies to platelet-derived growth factor-BB and basic fibroblast growth factor Atherosclerosis 130 1997 45 51
43. Y Sato, R Hamanaka, and J Ono The stimulatory effect of PDGF on vascular smooth muscle cell migration is mediated by the induction of endogenous basic FGF Biochem. Biophys. Res. Commun. 174 1991 1260 1266
44. A Segev, N Nili, and BH Strauss The role of perlecan in arterial injury and angiogenesis Cardiovasc. Res. 63 2004 603 610
45. PJ Silver, JP Moreau, and E Denholm Heparinase III limits rat arterial smooth muscle cell proliferation in vitro and in vivo Eur. J. Pharmacol. 351 1998 79 83
46. A Skaletz-Rorowski, K Pinkernell, and JR Sindermann Angiotensin AT1 receptor upregulates expression of basic fibroblast growth factor, basic fibroblast growth factor receptor and coreceptor in human coronary smooth muscle cells Basic Res. Cardiol. 99 2004 272 278
47. R Steinfeld, BH Van Den, and G David Stimulation of fibroblast growth factor receptor-1 occupancy and signaling by cell surface-associated syndecans and glypican J. Cell Biol. 133 1996 405 416
48. M Tallquist, and A Kazlauskas PDGF signaling in cells and mice Cytokine Growth Factor Rev. 15 2004 205 213
49. PK Tran, K Tran-Lundmark, and R Soininen Increased intimal hyperplasia and smooth muscle cell proliferation in transgenic mice with heparan sulfate-deficient perlecan Circ. Res. 94 2004 550 558
50. S Wang, X Ai, and SD Freeman QSulf1, a heparan sulfate 6-O-endosulfatase, inhibits fibroblast growth factor signaling in mesoderm induction and angiogenesis Proc. Natl. Acad. Sci. U. S. A. 101 2004 4833 4838
51. MCM Weiser, NA Grieshaber, and PE Schwartz Perlecan regulates Oct-1 gene expression in vascular smooth muscle cells Mol. Biol. Cell 8 1997 999 1011
52. JM Xuereb, JM Herbert, and P Sie Effects of heparin and related sulfated polysaccharides on tissue factor expression induced by mitogenic and non-mitogenic factors in human vascular smooth muscle cells Thromb. Haemost. 81 1999 151 156